KHPG: Subsidiary purchases Bank of China wealth management products for 1.7 billion yuanZhitong·Jun 9 at 04:37 AM03988+1.40%BACHY+1.55%
KHPG: "KH812 Intravitreal Injection" drug clinical trial approvedZhitong·May 19 at 05:41 AM002773-4.36%
The A-share landscape of 34 biopharmaceutical companies: Under the iceberg, who is swimming naked, and who has armor?新浪财经-财经头条·May 3 at 04:28 AM002773-4.36%000661-4.28%
KHPG released its first-quarter performance, with a net profit attributable to the parent company of 307 million yuan, a year-on-year decrease of 23.13%Zhitong·Apr 22 at 09:53 AM002773-4.36%
Healthcare Industry Daily (04.19): Frontline Dynamics in PharmaceuticalsEqualOcean·Apr 19 at 02:11 PM600557-3.89%002773-4.36%
KHPG's subsidiary KHN921 injection has received approval from the U.S. FDA to conduct clinical trialsZhitong·Apr 19 at 05:24 AM002773-4.36%
Significant performance increase, 300054, approaching the limit up! These stocks will be the first to release their Q1 reportse公司·Mar 26 at 11:07 PM002773-4.36%300054-40.00%
